Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines

Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cyclo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie International Edition 2023-08, Vol.62 (34), p.e202304672-n/a
Hauptverfasser: Liu, Yaowen, Dietl, Martin C., Heckershoff, Robin, Han, Chunyu, Shi, Hongwei, Rudolph, Matthias, Rominger, Frank, Caligiuri, Isabella, Asif, Kanwal, Adeel, Muhammad, Scattolin, Thomas, Hashmi, A. Stephen K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 34
container_start_page e202304672
container_title Angewandte Chemie International Edition
container_volume 62
creator Liu, Yaowen
Dietl, Martin C.
Heckershoff, Robin
Han, Chunyu
Shi, Hongwei
Rudolph, Matthias
Rominger, Frank
Caligiuri, Isabella
Asif, Kanwal
Adeel, Muhammad
Scattolin, Thomas
Hashmi, A. Stephen K.
description Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones. A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.
doi_str_mv 10.1002/anie.202304672
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2816758090</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2851805106</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</originalsourceid><addsrcrecordid>eNqFkc1qFTEYhoNYbG27dSkBNwWZ0_zNJF0Opz8eLO3CupIyZJIMpGaSY5KpTle9AcFr9EpMObVCN67yJXmelw9eAN5gtMAIkUPprVkQRChiDScvwA6uCa4o5_RlmRmlFRc13gavU7opvBCoeQW2KSeIEVHvgJ9nwenf97-WMks33xkNT0McpYNf2HtyDZezckFqbbMNHsoEW6VMSjAH2Pps8zSGWOxWZXtr4Ke1jUEVxSp4-cN6HZxJcIhhhK37OvtykV7DVZLZ-qIdm1g0DT-abEdbvvfA1iBdMvuP5y74fHpytfxQnV-erZbteaUYpqTSDaJcY450j6iiQ03YoLEYkEaMGyNk3fRYlWcue0GGgRmOG8YYkULJvunpLjjY5K5j-DaZlLvRJmWck96EKXVE4IbXAh2hgr57ht6EKfqyXaFqLFCNUVOoxYZSMaQUzdCtox1lnDuMuoeiuoeiuqeiivD2MXbqR6Of8L_NFOBoA3y3zsz_ievai9XJv_A_N8ajPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2851805106</pqid></control><display><type>article</type><title>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</title><source>Access via Wiley Online Library</source><creator>Liu, Yaowen ; Dietl, Martin C. ; Heckershoff, Robin ; Han, Chunyu ; Shi, Hongwei ; Rudolph, Matthias ; Rominger, Frank ; Caligiuri, Isabella ; Asif, Kanwal ; Adeel, Muhammad ; Scattolin, Thomas ; Hashmi, A. Stephen K.</creator><creatorcontrib>Liu, Yaowen ; Dietl, Martin C. ; Heckershoff, Robin ; Han, Chunyu ; Shi, Hongwei ; Rudolph, Matthias ; Rominger, Frank ; Caligiuri, Isabella ; Asif, Kanwal ; Adeel, Muhammad ; Scattolin, Thomas ; Hashmi, A. Stephen K.</creatorcontrib><description>Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones. A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.202304672</identifier><identifier>PMID: 37204285</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Additives ; Alkynes ; Antitumor Activity ; Biocompatibility ; Biological activity ; Carbamates (tradename) ; Catalysts ; Cycloaddition ; Functional groups ; Gold ; Gold Catalysis ; Imines ; Isatin-Derived Ketimines ; Spirocarbamates ; Tumor cell lines ; Tumor cells ; Tumors</subject><ispartof>Angewandte Chemie International Edition, 2023-08, Vol.62 (34), p.e202304672-n/a</ispartof><rights>2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH</rights><rights>2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</citedby><cites>FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</cites><orcidid>0000-0002-6720-8602</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fanie.202304672$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fanie.202304672$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37204285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yaowen</creatorcontrib><creatorcontrib>Dietl, Martin C.</creatorcontrib><creatorcontrib>Heckershoff, Robin</creatorcontrib><creatorcontrib>Han, Chunyu</creatorcontrib><creatorcontrib>Shi, Hongwei</creatorcontrib><creatorcontrib>Rudolph, Matthias</creatorcontrib><creatorcontrib>Rominger, Frank</creatorcontrib><creatorcontrib>Caligiuri, Isabella</creatorcontrib><creatorcontrib>Asif, Kanwal</creatorcontrib><creatorcontrib>Adeel, Muhammad</creatorcontrib><creatorcontrib>Scattolin, Thomas</creatorcontrib><creatorcontrib>Hashmi, A. Stephen K.</creatorcontrib><title>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</title><title>Angewandte Chemie International Edition</title><addtitle>Angew Chem Int Ed Engl</addtitle><description>Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones. A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.</description><subject>Additives</subject><subject>Alkynes</subject><subject>Antitumor Activity</subject><subject>Biocompatibility</subject><subject>Biological activity</subject><subject>Carbamates (tradename)</subject><subject>Catalysts</subject><subject>Cycloaddition</subject><subject>Functional groups</subject><subject>Gold</subject><subject>Gold Catalysis</subject><subject>Imines</subject><subject>Isatin-Derived Ketimines</subject><subject>Spirocarbamates</subject><subject>Tumor cell lines</subject><subject>Tumor cells</subject><subject>Tumors</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFkc1qFTEYhoNYbG27dSkBNwWZ0_zNJF0Opz8eLO3CupIyZJIMpGaSY5KpTle9AcFr9EpMObVCN67yJXmelw9eAN5gtMAIkUPprVkQRChiDScvwA6uCa4o5_RlmRmlFRc13gavU7opvBCoeQW2KSeIEVHvgJ9nwenf97-WMks33xkNT0McpYNf2HtyDZezckFqbbMNHsoEW6VMSjAH2Pps8zSGWOxWZXtr4Ke1jUEVxSp4-cN6HZxJcIhhhK37OvtykV7DVZLZ-qIdm1g0DT-abEdbvvfA1iBdMvuP5y74fHpytfxQnV-erZbteaUYpqTSDaJcY450j6iiQ03YoLEYkEaMGyNk3fRYlWcue0GGgRmOG8YYkULJvunpLjjY5K5j-DaZlLvRJmWck96EKXVE4IbXAh2hgr57ht6EKfqyXaFqLFCNUVOoxYZSMaQUzdCtox1lnDuMuoeiuoeiuqeiivD2MXbqR6Of8L_NFOBoA3y3zsz_ievai9XJv_A_N8ajPA</recordid><startdate>20230821</startdate><enddate>20230821</enddate><creator>Liu, Yaowen</creator><creator>Dietl, Martin C.</creator><creator>Heckershoff, Robin</creator><creator>Han, Chunyu</creator><creator>Shi, Hongwei</creator><creator>Rudolph, Matthias</creator><creator>Rominger, Frank</creator><creator>Caligiuri, Isabella</creator><creator>Asif, Kanwal</creator><creator>Adeel, Muhammad</creator><creator>Scattolin, Thomas</creator><creator>Hashmi, A. Stephen K.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6720-8602</orcidid></search><sort><creationdate>20230821</creationdate><title>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</title><author>Liu, Yaowen ; Dietl, Martin C. ; Heckershoff, Robin ; Han, Chunyu ; Shi, Hongwei ; Rudolph, Matthias ; Rominger, Frank ; Caligiuri, Isabella ; Asif, Kanwal ; Adeel, Muhammad ; Scattolin, Thomas ; Hashmi, A. Stephen K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4132-d6037d170db03c3f524fd18f0d047ee8a56b1cf527ab82ff4e7164442a8cab6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Additives</topic><topic>Alkynes</topic><topic>Antitumor Activity</topic><topic>Biocompatibility</topic><topic>Biological activity</topic><topic>Carbamates (tradename)</topic><topic>Catalysts</topic><topic>Cycloaddition</topic><topic>Functional groups</topic><topic>Gold</topic><topic>Gold Catalysis</topic><topic>Imines</topic><topic>Isatin-Derived Ketimines</topic><topic>Spirocarbamates</topic><topic>Tumor cell lines</topic><topic>Tumor cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yaowen</creatorcontrib><creatorcontrib>Dietl, Martin C.</creatorcontrib><creatorcontrib>Heckershoff, Robin</creatorcontrib><creatorcontrib>Han, Chunyu</creatorcontrib><creatorcontrib>Shi, Hongwei</creatorcontrib><creatorcontrib>Rudolph, Matthias</creatorcontrib><creatorcontrib>Rominger, Frank</creatorcontrib><creatorcontrib>Caligiuri, Isabella</creatorcontrib><creatorcontrib>Asif, Kanwal</creatorcontrib><creatorcontrib>Adeel, Muhammad</creatorcontrib><creatorcontrib>Scattolin, Thomas</creatorcontrib><creatorcontrib>Hashmi, A. Stephen K.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yaowen</au><au>Dietl, Martin C.</au><au>Heckershoff, Robin</au><au>Han, Chunyu</au><au>Shi, Hongwei</au><au>Rudolph, Matthias</au><au>Rominger, Frank</au><au>Caligiuri, Isabella</au><au>Asif, Kanwal</au><au>Adeel, Muhammad</au><au>Scattolin, Thomas</au><au>Hashmi, A. Stephen K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew Chem Int Ed Engl</addtitle><date>2023-08-21</date><risdate>2023</risdate><volume>62</volume><issue>34</issue><spage>e202304672</spage><epage>n/a</epage><pages>e202304672-n/a</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><abstract>Due to its excellent bioactivity profile, which is increasingly utilized in pharmaceutical and synthetic chemistry, spirooxindole is an important core scaffold. We herein describe an efficient method for the construction of highly functionalized new spirooxindolocarbamates via a gold‐catalyzed cycloaddition reaction of terminal alkynes or ynamides with isatin‐derived ketimines. This protocol has a good functional group compatibility, uses readily available starting materials, mild reaction conditions, low catalyst loadings and no additives. It enables the transformation of various functionalized alkyne groups into cyclic carbamates. Gram‐scale synthesis was achieved and DFT calculations verify the feasibility of the mechanistic proposal. Some of the target products exhibit good to excellent antiproliferative activity on human tumor cell lines. In addition, one of the most active compounds displayed a remarkable selectivity towards tumor cells over normal ones. A novel protocol for the synthesis of spirooxindoles that possess excellent antiproliferative activity on human tumor cell lines was achieved through a gold‐catalyzed cycloaddition reaction of alkynes with isatin‐derived ketimines. Various functionalized and readily available alkynes reacted under mild reaction conditions.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37204285</pmid><doi>10.1002/anie.202304672</doi><tpages>8</tpages><edition>International ed. in English</edition><orcidid>https://orcid.org/0000-0002-6720-8602</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1433-7851
ispartof Angewandte Chemie International Edition, 2023-08, Vol.62 (34), p.e202304672-n/a
issn 1433-7851
1521-3773
language eng
recordid cdi_proquest_miscellaneous_2816758090
source Access via Wiley Online Library
subjects Additives
Alkynes
Antitumor Activity
Biocompatibility
Biological activity
Carbamates (tradename)
Catalysts
Cycloaddition
Functional groups
Gold
Gold Catalysis
Imines
Isatin-Derived Ketimines
Spirocarbamates
Tumor cell lines
Tumor cells
Tumors
title Gold‐Catalyzed Formal [4+2] Cycloaddition as Access to Antitumor‐Active Spirocyclic Oxindoles from Alkynes and Isatin‐Derived Ketimines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T16%3A03%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gold%E2%80%90Catalyzed%20Formal%20%5B4+2%5D%20Cycloaddition%20as%20Access%20to%20Antitumor%E2%80%90Active%20Spirocyclic%20Oxindoles%20from%20Alkynes%20and%20Isatin%E2%80%90Derived%20Ketimines&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Liu,%20Yaowen&rft.date=2023-08-21&rft.volume=62&rft.issue=34&rft.spage=e202304672&rft.epage=n/a&rft.pages=e202304672-n/a&rft.issn=1433-7851&rft.eissn=1521-3773&rft_id=info:doi/10.1002/anie.202304672&rft_dat=%3Cproquest_cross%3E2851805106%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2851805106&rft_id=info:pmid/37204285&rfr_iscdi=true